财务
- Market Capitalization 11.48 M
- Employee 113
- Founded 2001
- CEO Yaky Yanay
- Website www.pluri-biotech.com
- Headquarter Nevada, United States
- FIGI BBG000DQX509
- Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
-0.86
市销率
—
相关股票代码
| # | 姓名 | 价格 | 24小时 % | 7天 % | 一个月 % | 一年 % | 市值 | 最近7天 | |
|---|---|---|---|---|---|---|---|---|---|
| 4612 | INAB IN8bio, Inc. - Common Stock | 1.20 USD | +1.69% | -14.29% | +13.21% | -28.14% | 11.83 M USD | ||
| 4616 | ASBP Aspire Biopharma Holdings, Inc. - Common Stock | 8.16 USD | -0.73% | -6.85% | +1.37% | +423.08% | 11.44 M USD | ||
| 4618 | AEON AEON Biopharma, Inc. Class A Common Stock | 0.23 USD | 0.00% | -25.81% | -14.81% | -77.88% | 11.47 M USD | ||
| 4620 | INTS Intensity Therapeutics, Inc. - Common Stock | 3.42 USD | -3.66% | -9.04% | -10.47% | +1121.43% | 11.17 M USD |